发明授权
EP1732917B8 AUSGEWAHLTE CGRP-ANTAGONISTEN, VERFAHREN ZU DEREN HERSTELLUNG SOWIE DEREN VERWENDUNG ALS ARZNEIMITTEL
有权
SELECTED CGRP拮抗剂，它们的生产方法及其作为药物
- 专利标题： AUSGEWAHLTE CGRP-ANTAGONISTEN, VERFAHREN ZU DEREN HERSTELLUNG SOWIE DEREN VERWENDUNG ALS ARZNEIMITTEL
- 专利标题（英）： Selected cgrp antagonists, methods for the production thereof and their use as medicaments
- 专利标题（中）： SELECTED CGRP拮抗剂，它们的生产方法及其作为药物
-
申请号： EP05741783.4申请日： 2005-03-23
-
公开(公告)号： EP1732917B8公开(公告)日： 2009-09-09
- 发明人: MUELLER, Stephan, Georg , RUDOLF, Klaus , LUSTENBERGER, Philipp , STENKAMP, Dirk , DREYER, Alexander , ARNDT, Kirsten , DOODS, Henri , SCHAENZLE, Gerhard , SANTAGOSTINO, Marco , PALEARI, Fabio
- 申请人： BOEHRINGER INGELHEIM INTERNATIONAL GMBH , Boehringer Ingelheim Pharma GmbH & Co. KG
- 申请人地址： Binger Str. 173 55216 Ingelheim DE
- 专利权人： BOEHRINGER INGELHEIM INTERNATIONAL GMBH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人： BOEHRINGER INGELHEIM INTERNATIONAL GMBH,Boehringer Ingelheim Pharma GmbH & Co. KG
- 当前专利权人地址： Binger Str. 173 55216 Ingelheim DE
- 代理机构： Hammann, Heinz
- 优先权： DE102004015723 20040329
- 国际公布： WO2005092880 20051006
- 主分类号： C07D401/04
- IPC分类号： C07D401/04 ; C07D401/14 ; A61K31/551 ; A61P25/06
摘要：
The invention relates to CGRP antagonists of general formula (I), in which A, X, D, E, G, M, Q and R1 to R3 are defined as in Claim 1, to their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and their salts as well as the hydrates of the salts, particularly their physiologically compatible salts having inorganic or organic acids, to medicaments containing these compounds, to their use, and to methods for the production thereof.
公开/授权文献
信息查询
